Loại tài liệu:    Chỉ tìm trong: 
11-20 trong số 42 kết quả
A study to learn how well quizartinib with chemotherapy works and how safe it is in people with acute myeloid leukemia t...
Tác giả: Harry P Erba
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  625.79
 
Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of li...
Tác giả: Stephen J Freedland, Martin Gleave, Yiyun Tang, Arijit Ganguli, Gabriel P Haas, Neal D Shore, Ugo De Giorgi, Antti Rannikko, Christopher M Pieczonka, Ronald F Tutrone, Balaji Venugopal, Henry H Woo, Miguel Ramirez-Backhaus, Jamal Tarazi
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  006.74
 
BioPearl™ doxorubicin microspheres for unresectable HCC: a prospective, single-arm, multicenter study: BIOPEARL-ONE
Tác giả: Gontran Verset, Roberto Iezzi, Irene Bargellini, Ana-Maria Bucalau, Philippe Pereira, Gerd Groezinger, Carlo Spreafico, Geert Maleux
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  551.51
 
A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people ...
Tác giả: Dirk Schadendorf, Reinhard Dummer, Liszkay Liszkay, Carmen Loquai, Mario Mandalà, Naoya Yamazaki, Paola Queirolo, Carolin Guenzel, Anna Polli, Mahgull Thakur, Alessandra di Pietro, Paolo A Ascierto, Keith T Flaherty, Caroline Robert, Ana Arance, Jan Willem B de Groot, Claus Garbe, Helen J Gogas, Ralf Gutzmer, Ivana Krajsová
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  006.74
 
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib
Tác giả: Francesco Passamonti, Siddhi Korgaonkar, Rohan C Parikh, Manoj Chevli, Aylin Yucel, Julien Rombi, Shalon Jones, Dorothy Zissler, Keith L Davis, Samantha Slaff
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  004.338
 
Evaluating patients on CDK-4/6 inhibitor treatment for differences in treatment according to demographic variables
Tác giả: Sneha Rajendran, Marina Petruzzi, Dianxu Ren, Catherine Bender, Adam Brufsky, Margaret Q Rosenzweig
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  296.315
 
Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors
Tác giả: Kevin Harrington, Shigehisa Kitano, Michael Schmohl, José Barrueco, Patricia LoRusso, Valentina Gambardella, Eileen E Parkes, Irene Moreno, Guzman Alonso, Toshihiko Doi, David Berz, Martin E Gutierrez, Natalia Fernandez
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  553.79
 
Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitations
Tác giả: Abhay H Pande, J Anakha, Yenisetti Rajendra Prasad
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  746.72
 
Earlier versus delayed ruxolitinib treatment for patients with myelofibrosis: a plain language summary
Tác giả: Claire Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro M Vannucchi
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  553.453
 
Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study)...
Tác giả: Michiel S van der Heijden, Aristotelis Bamias, Jens Bedke, Philippe Beuzeboc, Mauricio Burotto, Gurkamal Chatta, Jeiry Filian, Matthew D Galsky, Zhisong He, Ja Hyeon Ku, Federico Nasroulah, Andrea Necchi, Jan Oldenburg, Miraj Y Patel, Thomas Powles, Daniela Purcea, Juan Pablo Sade, Michael Schenker, Guru Sonpavde, Yoshihiko Tomita, Yüksel Ürün, Begoña P Valderrama, Lily Wang, Dingwei Ye
Xuất bản: England: Future oncology (London, England , 2025
Bộ sưu tập: NCBI
ddc:  001.4226
 

Truy cập nhanh danh mục